Generic Name : NATEGLINIDE
TradeName : GLINATE tab NATELIDE tab NATIZ tab NDS tab
Why it is prescribed (Indications) : This medication is prescribed for type 2 diabetes. It lowers blood sugar level by speeding up the release of insulin from the pancreas. It used along with diet and exercise.
When it is not to be taken (Contraindications) : Diabetic ketoacidosis; IDDM ( Insulin-Dependent Diabetes Mellitus) or type I diabetes, lactation.
When it is to be taken : Oral: 60 to 120 mg 3 times/day, up to 180 mg 3 times/day if needed.
How it should be taken : It comes as a tablet to take by mouth. It is usually taken three times daily. Take this medication any time from 30 minutes before a meal to just before the meal. If you skip a meal, you need to skip the dose of this medication.
Special Instruction :
*Strenuous exercise, drinking alcohol, fever, surgery, trauma, dieting, and skipping meals can affect your blood sugar levels. *Caution should be exercised in patients with history of fever, infection, injury, or illness with vomiting or diarrhea, liver or pituitary disease, kidney impairment, disease of the nervous system, and diabetes. *Monitor sugar level during periods of stress.
Side Effects :
METABOLIC-NUTRITIONAL- Low blood sugar (these may include cold sweats, cool pale skin, tremor, anxious feeling, unusual tiredness or weakness, confusion, difficulty in concentration, excessive hunger, temporary vision changes, headache or nausea).
CENTRAL NERVOUS SYSTEM- Dizziness.
GI- Diarrhea, nausea.
LIVER- Jaundice due to the bile obstruction from the liver, elevated LFTs(Liver function test).
HYPERSENSITIVITY- Rash, itching, hives.
RESPIRATORY- Upper respiratory tract infection, inflammation of bronchus, coughing.
MISCELLANEOUS- Back pain, flu-like symptoms, joint diseases, accidental trauma.
Other Precautions :
*Follow the diet program given to you.*To prevent low blood sugar, eat meals at the same time each day and do not skip meals.
Storage Conditions :
Oral: Store it at room temperature and keep in airtight container.
No comments:
Post a Comment